Behavioral Physical Activity Intervention for Women With HIV and Hypertension
Peer support
+ Exercise Prescription
+ Blood pressure self monitoring
Cardiovascular Diseases
+ Hypertension
+ Vascular Diseases
Prevention Study
Summary
Study start date: October 1, 2025
Actual date on which the first participant was enrolled.This study aims to test a special program that encourages women aged 40 and above, who are living with both HIV and high blood pressure, to be more physically active. The program includes guidance on exercise, support from peers, and tools to monitor blood pressure at home. By understanding how well these elements work together, the study seeks to improve the health and quality of life for these women. This research is significant because managing both HIV and hypertension can be challenging, and finding effective ways to help individuals manage these conditions can lead to better overall health outcomes. Participants in the study will be randomly assigned to try the physical activity program. They will receive personalized exercise advice, have access to peer support, and use home devices to track their blood pressure. Researchers will evaluate how feasible and acceptable these strategies are, as well as measure changes in blood pressure, physical activity levels, confidence in exercising, social support, and overall quality of life. The study aims to see if this approach can effectively encourage more physical activity and improve health for the participants.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Over 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * woman living with HIV * age 40 and above * diagnosed with HTN * access to a personal phone for study-related phone calls * willing to wear an accelerometer on their waist or hip for 7 days at beginning and end of 12-week intervention * able to ambulate independently * English speaking Exclusion Criteria: * Pregnant * unable to provide informed consent due to cognitive deficit, serious mental illness, or active substance use
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Department of Family & Community Medicine; University of Alabama at Birmingham
Birmingham, United StatesSee the location